Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib–rituximab

Saved in:

Bibliographic Details
Published in:	Blood Cancer J
Main Authors:	Gentile, Massimo, Martino, Enrica Antonia, Visentin, Andrea, Coscia, Marta, Reda, Gianluigi, Sportoletti, Paolo, Mauro, Francesca Romana, Laurenti, Luca, Varettoni, Marzia, Murru, Roberta, Chiarenza, Annalisa, Vigna, Ernesto, Mendicino, Francesco, Lucia, Eugenio, Bossio, Sabrina, Recchia, Anna Grazia, Moia, Riccardo, Pietrasanta, Daniela, Loseto, Giacomo, Consoli, Ugo, Scortechini, Ilaria, Rossi, Francesca Maria, Zucchetto, Antonella, Al-Janazreh, Hamdi, Vitale, Candida, Tripepi, Giovanni, D’Arrigo, Graziella, Angeletti, Ilaria, Bomben, Riccardo, Neri, Antonino, Cutrona, Giovanna, Fronza, Gilberto, Di Raimondo, Francesco, Gaidano, Gianluca, Cuneo, Antonio, Foà, Robin, Ferrarini, Manlio, Trentin, Livio, Gattei, Valter, Morabito, Fortunato
Format:	Artigo
Language:	Inglês
Published:	Nature Publishing Group UK 2020
Subjects:	Correspondence
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC7494850/ https://ncbi.nlm.nih.gov/pubmed/32938904 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-020-00358-3
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items